MannKind Corp (MNKD)
7.02
+0.06
(+0.86%)
USD |
NASDAQ |
Nov 14, 16:00
7.025
0.00 (0.00%)
After-Hours: 20:00
MannKind Gross Profit (Annual): 136.19M for Dec. 31, 2023
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 136.19M |
| December 31, 2022 | 42.27M |
| December 31, 2021 | 36.58M |
| December 31, 2020 | 40.50M |
| December 31, 2019 | 35.06M |
| December 31, 2018 | 7.39M |
| December 31, 2017 | -5.483M |
| December 31, 2016 | 124.67M |
| December 31, 2015 | -64.74M |
| Date | Value |
|---|---|
| December 31, 2014 | 0.00 |
| December 31, 2013 | |
| December 31, 2012 | |
| December 31, 2011 | |
| December 31, 2010 | |
| December 31, 2009 | 0.00 |
| December 31, 2008 | 0.02M |
| December 31, 2007 | 0.01M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Annual) Range, Past 5 Years
35.06M
Minimum
2019
136.19M
Maximum
2023
58.12M
Average
40.50M
Median
2020
Gross Profit (Annual) Benchmarks
| Mirum Pharmaceuticals Inc | 139.34M |
| NovaBay Pharmaceuticals Inc | 7.895M |
| Palatin Technologies Inc | 4.392M |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |